Experimental Hematology
Volume 35, Issue 12 , Pages 1812-1822 , December 2007

Constitutive association of MyD88 to IRAK in HTLV-I–transformed T cells

  • Takamitsu Mizobe

      Affiliations

    • The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
    • ,
  • Junichi Tsukada

      Affiliations

    • Cancer Chemotherapy Center, University of Occupational and Environmental Health, Kitakyushu, Japan
    • Corresponding Author InformationOffprint requests to: Junichi Tsukada, Ph.D., M.D., Cancer Chemotherapy Center, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan
    • ,
  • Takehiro Higashi

      Affiliations

    • The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
    • ,
  • Fumihiko Mouri

      Affiliations

    • The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
    • ,
  • Ai Matsuura

      Affiliations

    • The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
    • ,
  • Rena Tanikawa

      Affiliations

    • The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
    • ,
  • Yasuhiro Minami

      Affiliations

    • Department of Genome Sciences, Faculty of Medical Sciences, Graduate School of Medicine, Kobe University, Kobe, Japan
    • ,
  • Yasuhiro Yoshida

      Affiliations

    • Department of Immunology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
    • ,
  • Yoshiya Tanaka

      Affiliations

    • The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan

Received 28 August 2006 ,Revised 6 August 2007 ,Accepted 7 August 2007.

References 

  1. Sagawa K, Mochizuki M, Masuoka K, et al. Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis. Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production. J Clin Invest. 1995;95:852–858
  2. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A. 1982;79:2031–2035
  3. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77:7415–7419
  4. Hironaka N, Mochida K, Mori N, Maeda M, Yamamoto N, Yamaoka S. Tax-independent constitutive IκB kinase activation in adult T-cell leukemia cells. Neoplasia. 2004;6:266–278
  5. Mori N, Fujii M, Ikeda S, et al. Constitutive activation of NF-κB in primary adult T-cell leukemia cells. Blood. 1999;93:2360–2368
  6. Portis T, Harding JC, Ratner L. The contribution of NF-κB activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors. Blood. 2001;98:1200–1208
  7. Geleziunas R, Ferrell S, Lin X, et al. Human T-cell leukemia virus type 1 Tax induction of NF-κB involves activation of the IκB kinase alpha (IKKα) and IKKβ cellular kinases. Mol Cell Biol. 1998;18:5157–5165
  8. Arima N, Matsushita K, Obata H, et al. NF-κB involvement in the activation of primary adult T-cell leukemia cells and its clinical implications. Exp Hematol. 1999;27:1168–1175
  9. Mori N, Yamada Y, Ikeda S, et al. Bay 11-7082 inhibits transcription factor NF-κB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood. 2002;100:1828–1834
  10. Watanabe M, Ohsugi T, Shoda M, et al. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-κB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood. 2005;106:2462–2471
  11. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335–376
  12. Dunne A, O'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE. 2003;2003:re3
  13. Muzio M, Polentarutti N, Bosisio D, Manoj Kumar PP, Mantovani A. Toll-like receptor family and signalling pathway. Biochem Soc Trans. 2000;28:563–566
  14. Akira S, Yamamoto M, Takeda K. Role of adapters in Toll-like receptor signalling. Biochem Soc Trans. 2003;31:637–642
  15. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2:675–680
  16. O'Neill LA. The role of MyD88-like adapters in Toll-like receptor signal transduction. Biochem Soc Trans. 2003;31:643–647
  17. Akira S. Toll-like receptor signaling. J Biol Chem. 2003;278:38105–38108
  18. Janssens S, Beyaert R. A universal role for MyD88 in TLR/IL-1R-mediated signaling. Trends Biochem Sci. 2002;27:474–482
  19. Burns K, Martinon F, Esslinger C, et al. MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem. 1998;273:12203–12209
  20. Boch JA, Yoshida Y, Koyama Y, et al. Characterization of a cascade of protein interactions initiated at the IL-1 receptor. Biochem Biophys Res Commun. 2003;303:525–531
  21. Higashi T, Tsukada J, Yoshida Y, et al. Constitutive tyrosine and serine phosphorylation of STAT4 in T-cells transformed with HTLV-I. Genes Cells. 2005;10:1153–1162
  22. Mori N, Prager D. Transactivation of the interleukin-1α promoter by human T-cell leukemia virus type I and type II Tax proteins. Blood. 1996;87:3410–3417
  23. Barbulescu K, Becker C, Schlaak JF, Schmitt E, Meyer zum Buschenfelde KH, Neurath MF. IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-γ promoter in primary CD4+ T lymphocytes. J Immunol. 1998;160:3642–3647
  24. Geist LJ, Hopkins HA, Dai LY, He B, Monick MM, Hunninghake GW. Cytomegalovirus modulates transcription factors necessary for the activation of the tumor necrosis factor-α promoter. Am J Respir Cell Mol Biol. 1997;16:31–37
  25. Tsukada J, Misago M, Serino Y, et al. Human T-cell leukemia virus type I Tax transactivates the promoter of human prointerleukin-1β gene through association with two transcription factors, nuclear factor-interleukin-6 and Spi-1. Blood. 1997;90:3142–3153
  26. Tsunekawa B, Wada M, Ikeda M, et al. The binding between the stem regions of human growth hormone (GH) receptor compensates for the weaker site 1 binding of 20-kDa human GH (hGH) than that of 22-kDa hGH. J Biol Chem. 2000;275:15652–15656
  27. Miyairi S, Tateda K, Fuse ET, et al. Immunization with 3-oxododecanoyl-L-homoserine lactone-protein conjugate protects mice from lethal Pseudomonas aeruginosa lung infection. J Med Microbiol. 2006;55:1381–1387
  28. Schaefer TM, Desouza K, Fahey JV, Beagley KW, Wira CR. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology. 2004;112:428–436
  29. Mori N, Shirakawa F, Shimizu H, et al. Transcriptional regulation of the human interleukin-6 gene promoter in human T-cell leukemia virus type I-infected T-cell lines: evidence for the involvement of NF-κB. Blood. 1994;84:2904–2911
  30. Adachi O, Kawai T, Takeda K, et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 1998;9:143–150
  31. Gelman AE, Zhang J, Choi Y, Turka LA. Toll-like receptor ligands directly promote activated CD4+ T cell survival. J Immunol. 2004;172:6065–6073
  32. Crellin NK, Garcia RV, Hadisfar O, Allan SE, Steiner TS, Levings MK. Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J Immunol. 2005;175:8051–8059
  33. Caron G, Duluc D, Fremaux I, et al. Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-γ production by memory CD4+ T cells. J Immunol. 2005;175:1551–1557
  34. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med. 2003;197:403–411
  35. Jefferies C, Bowie A, Brady G, Cooke EL, Li X, O'Neill LA. Transactivation by the p65 subunit of NF-κB in response to interleukin-1 (IL-1) involves MyD88, IL-1 receptor-associated kinase 1, TRAF-6, and Rac1. Mol Cell Biol. 2001;21:4544–4552
  36. Azimi N, Brown K, Bamford RN, Tagaya Y, Siebenlist U, Waldmann TA. Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-κB site. Proc Natl Acad Sci U S A. 1998;95:2452–2457
  37. Kanno T, Brown K, Franzoso G, Siebenlist U. Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-κB. Mol Cell Biol. 1994;14:6443–6451
  38. Harhaj EW, Sun SC. IKKγ serves as a docking subunit of the IκB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. J Biol Chem. 1999;274:22911–22914
  39. Jin DY, Giordano V, Kibler KV, Nakano H, Jeang KT. Role of adapter function in oncoprotein-mediated activation of NF-κB. Human T-cell leukemia virus type I Tax interacts directly with IκB kinase γ. J Biol Chem. 1999;274:17402–17405
  40. Huang GJ, Zhang ZQ, Jin DY. Stimulation of IKK-γ oligomerization by the human T-cell leukemia virus oncoprotein Tax. FEBS Lett. 2002;531:494–498
  41. Higuchi M, Matsuda T, Mori N, et al. Elevated expression of CD30 in adult T-cell leukemia cell lines: possible role in constitutive NF-κB activation. Retrovirology. 2005;2:29
  42. Claudio E, Brown K, Park S, Wang H, Siebenlist U. BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells. Nat Immunol. 2002;3:958–965
  43. Kayagaki N, Yan M, Seshasayee D, et al. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-κB2. Immunity. 2002;17:515–524
  44. Dejardin E, Droin NM, Delhase M, et al. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-κB pathways. Immunity. 2002;17:525–535
  45. Saitoh T, Nakano H, Yamamoto N, Yamaoka S. Lymphotoxin-β receptor mediates NEMO-independent NF-κB activation. FEBS Lett. 2002;532:45–51
  46. Coope HJ, Atkinson PG, Huhse B, et al. CD40 regulates the processing of NF-κB2 p100 to p52. EMBO J. 2002;21:5375–5385
  47. Saitoh T, Nakayama M, Nakano H, Yagita H, Yamamoto N, Yamaoka S. TWEAK induces NF-κB2 p100 processing and long lasting NF-κB activation. J Biol Chem. 2003;278:36005–36012
  48. Kitajima I, Shinohara T, Bilakovics J, Brown DA, Xu X, Nerenberg M. Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-κB. Science. 1992;258:1792–1795
  49. Yamada Y, Ohmoto Y, Hata T, et al. Features of the cytokines secreted by adult T cell leukemia (ATL) cells. Leuk Lymphoma. 1996;21:443–447
  50. Grossman WJ, Ratner L. Cytokine expression and tumorigenicity of large granular lymphocytic leukemia cells from mice transgenic for the tax gene of human T-cell leukemia virus type I. Blood. 1997;90:783–794
  51. Mori N, Gill PS, Mougdil T, Murakami S, Eto S, Prager D. Interleukin-10 gene expression in adult T-cell leukemia. Blood. 1996;88:1035–1045
  52. Franchini G. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood. 1995;86:3619–3639
  53. Siekevitz M, Feinberg MB, Holbrook N, Wong-Staal F, Greene WC. Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I. Proc Natl Acad Sci U S A. 1987;84:5389–5393
  54. Mercurio F, Zhu H, Murray BW, et al. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science. 1997;278:860–866
  55. Perkins ND. Achieving transcriptional specificity with NF-κB. Int J Biochem Cell Biol. 1997;29:1433–1448
  56. Faggioli L, Costanzo C, Merola M, et al. Nuclear factor κB (NF-κB), nuclear factor interleukin-6 (NFIL-6 or C/EBPβ) and nuclear factor interleukin-6β (NFIL6-β or C/EBPδ) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7. Comparative analysis with MDA-MB-231 cells, an interleukin-6-expressing human breast carcinoma cell line. Eur J Biochem. 1996;239:624–631
  57. Washizu J, Nishimura H, Nakamura N, Nimura Y, Yoshikai Y. The NF-κB binding site is essential for transcriptional activation of the IL-15 gene. Immunogenetics. 1998;48:1–7
  58. Schmitz ML, Baeuerle PA. Multi-step activation of NF-κB/Rel transcription factors. Immunobiology. 1995;193:116–127

PII: S0301-472X(07)00496-1

doi: 10.1016/j.exphem.2007.08.008

Experimental Hematology
Volume 35, Issue 12 , Pages 1812-1822 , December 2007

Article Tools

* Image Usage & Resolution